AstraZeneca (AZN)
(Delayed Data from NSDQ)
$73.95 USD
+0.86 (1.18%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $74.02 +0.07 (0.09%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, AstraZeneca PLC has a market cap of $226.68B, which represents its share price of $73.09 multiplied by its outstanding shares number of 3.10B. As a large-cap company, AZN's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AZN 73.95 +0.86(1.18%)
Will AZN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AZN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AZN
Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?
AZN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Other News for AZN
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
European pharmaceutical stocks slip after Trump pushes for lower drug prices
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Press Secretary says Trump sent letters today to pharmaceutical companies